These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 16337942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E, Pardo LA, Gold R, Linker RA.
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [Abstract] [Full Text] [Related]

  • 8. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
    Huizinga R, Gerritsen W, Heijmans N, Amor S.
    Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
    Black JA, Liu S, Hains BC, Saab CY, Waxman SG.
    Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
    [Abstract] [Full Text] [Related]

  • 11. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Jackson SJ, Lee J, Nikodemova M, Fabry Z, Duncan ID.
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):616-25. PubMed ID: 19458548
    [Abstract] [Full Text] [Related]

  • 12. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Jun; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA, Welsh ME, Carter DE, Karlik SJ.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483
    [Abstract] [Full Text] [Related]

  • 18. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F.
    Autoimmunity; 2008 Aug 30; 41(5):405-13. PubMed ID: 18568646
    [Abstract] [Full Text] [Related]

  • 19. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.
    J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of alpha-synuclein in neurons and glia in inflammatory demyelinating disease.
    Papadopoulos D, Ewans L, Pham-Dinh D, Knott J, Reynolds R.
    Mol Cell Neurosci; 2006 Apr 01; 31(4):597-612. PubMed ID: 16503161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.